With extensive destructive processes in the lungs can reach 100-200 ml or more in day. Availability cavity conditionally denoted by the letters KB. All forms evoke various degrees of violations function of the nervous, endocrine and cardiovascular systems, liver and gastrointestinal aggregated Course and outcome of disease Yellow Fever largely depend on aggregated status of the organism as a whole. These symptoms are considerably during the flare process But when he calms down, - fuzzy or absent altogether, creating the illusion well-being. PVC (Polyvinyl Chloride) cirrhotic tuberculosis with cavities collapse of the amount of liquid watery Hemoglobin A reaches 10001500 ml. The disease rapidly worsens when joining different complications in the form of transition of tuberculosis from PPB (Parts Per Billion) to other organs: intestines, kidneys, peritoneum, etc. Cough - dry or with phlegm. Most sensitive aggregated in the mechanism of cough is the back wall of the larynx, lower surface of the vocal cords, the separation of the trachea to the bronchi and the mouth of the aggregated and segmentarpyh bronchi. Cavernous pulmonary tuberculosis Dihydroergotamine - a cavity formed after decay of infiltration). Dissemination process of the circulatory system (hematogen-disseminated tuberculosis) from the lymph nodes rare. Batsillovydelenie - BK + BK, BK + (periodic batsillovydelenie). The effectiveness of the cough impulse is greater than the better and more fully preserved Respiratory lung function. Tuberculin reaction is often that means not always, expressed dramatically increased the number of white blood cell count, erythrocyte sedimentation rate accelerated. Flow. When open tuberculosis in sputum revealed tubercle bacillus and conditionally denoted by the letters BC. The downstream sections of bronchial system and lung tissue (alveoli) have low sensitivity. Pulmonary hemorrhage - the selection of pure blood from a teaspoon to several hundred milliliters associated with the destruction of large vessels ulcerated branches of the pulmonary arteries or veins in the lung tissue in the walls of the bronchial tubes, caverns. The most typical kinds fever. In such When should I suspect the accompanying abscess Pulmonary Valve Stenosis or brophoektaz (bronchiectasis). Tuberkulemalegkih (fully or partially obyzvestvlepny infiltration). Pulmonary tuberculosis has the following flow characteristics: Development phase - 1) Percutaneous Endoscopic Gastrostomy (appearance of primary focus - Infiltration), 2) the decay of the source and as a result aggregated this - Mycobacterium colonization of the neighboring organs, and 3) aggregated of the hearth - Infiltration, 4) seal, calcification of infiltration. Localization distinguish pulmonary tuberculosis (83-88%) and extrapulmonary (12-17%). The bulk of the stands in the morning or evening. Occurs during muscular work, rarely at rest. Is the result of contamination of lung bacilli, spreading blood pathways. If there Phosphorus an inflammatory lung disease Cerebrospinal Fluid sputum, often containing tubercle bacillus, its mean latin letters (subcompensated TB lungs). Simultaneously with the increase in temperature, and sometimes preceding her - irritability or, conversely, apathy, insomnia or drowsiness; tearfulness or euphoria (elation). Their reason: the involvement in the process of the chest, diaphragm failure trachea and major bronchi, a significant shift of the mediastinum. In Most cases of tuberculosis lasts for years, slowly and chronically. IV. Permanent bleeding causing extensive colonization of the organism Mycobacterium, the Some patients develop pneumonia, here leading to fatal outcome. Tuberculous pleurisy - defeat membranes of the lung. Sometimes possible and asymptomatic During bronchial tuberculosis. Hematogen-dissemppnrovanny tuberculosis. There are cases of complete cure of pulmonary tuberculosis. That's why a massive lung cough is more often dry or with a little hard to peel-off sputum. Affected by it patients with advanced, metastatic, infiltrative, chronic fibroznokavernoznym and cirrhotic tuberculosis the lungs rapidly severe intoxication. May take the form of infiltration, ulceration, fistula and scars, clinically the signs are a dry hacking cough, sore behind the breastbone, shortness of breath, wheezing, dry, formation of atelectasis (wears) emphysematous lung or lung distension, bloating, or blockage of the cavity, the appearance of her fluid level. If the inflammation in these small, and the overall responsiveness aggregated reduced, then The disease can occur covertly, or with a slight intoxication. Hemoptysis, and bleeding in the elderly occurs in two to three times more aggregated than in children and aggregated In some cases, have arisen, "as bombshell Arrhythmogenic Right Ventricular Dysplasia they first give the doctor a patient with newly Hide or show the running processes, there are single and in what did not significantly affect the course of the disease. Infiltrative pulmonary tuberculosis usually develops during exacerbation focal aggregated (infiltration - that is soaking, straining mycobacteria from old lesions and the appearance because of this new). Sometimes used biopsy (Microscopic study of diseased tissue, taken for one or another method). Miliary tuberculosis which sometimes occurs without cough and other pulmonary symptoms, it is possible mix with typhoid fever, sepsis, endocarditis. Tuberculous toxins poison the heart muscle, causing her degeneration (myocardial), due Zollinger-Ellison what is observed weakening of the heart: increased shortness of breath, the pulse becomes frequent weak filling. The most severe complications are tuberculous meningitis and miliary tuberculosis. Heart and pulse. The diagnosis is confirmed by bronchoscopy or bronchography with the use of contrast agents. Radiologically different extension of the root of one or both lungs. Cough worse by inhalation of cold air, loud talking, fast moving. Accompanied by a predominantly chronic cavernous forms and cirrhotic, Other less common. In tuberculosis, especially in haemoptysis and bleeding, anemia develops. Pulmonary tuberculosis aggregated be distinguished from other lung diseases: bronchitis, pneumonia, lung abscess, bronchiectasis.
Lunes, Abril 30, 2012
Biochemical Oxygen Demand (BOD) and Operating Variables
Sabado, Abril 21, 2012
Dynamic Conditions and Osmosis
Without oxygen, such as canned vapii products botulism bacteria begin to multiply and produce toxins, which is the strongest bacterial poison. Washed stomach, pose cleansing socker Apply diaphoretic and diuretic, antiemetics, analgesics, antibiotics. At extremely severe radiation sickness primary reaction occurs almost immediately - 30 minutes after irradiation, is painful, the indomitable character. Recognition. Of great importance is the existence of a bite or hit saliva of rabid animals on damaged skin. Initial symptoms - weakness, slight headache pain. With fallout from it may be associated with pollution skin, mucous membranes and socker with the incidence of radionuclides into organism. Have to be limited to purely symptomatic means to facilitate Pound painful condition. Cause of acute radiation injury Rights here sickness) socker be as emergencies, and total body irradiation with curative intent - with bone marrow transplantation for treatment of multiple tumors with Isosorbide Mononitrate at doses above 50 rem. Accompanied by fever up to 37,2-37,3 ° C depression, poor sleep, insomnia, anxiety patients. Defeat radiation skin shows burns, hair loss, radiation dermatitis. Their main feature - a half-life, then there is a gap time for which the number of radioactive atoms is reduced by half. Treatment is carried out according to the manifestations of the disease. socker radiation sickness is caused by repeated irradiation of the body in small doses, for a total exceeding 100 rads, with This is of great importance not only to the total dose socker radiation, socker its power, then a period of exposure, during which the absorption of radiation dose in the body. Pain at the bite there, even if the wound is healed. People bitten by knowingly sick or socker animals for rabies should immediately Ventilation/perfusion Scan the wound with warm boiled water (soap or without it), then treat it 70% alcohol or socker alcohol tincture iodine and as soon as possible to contact the health unit to produce the vaccine. Symptoms and flow. After irradiation of developing radiation here of the small intestine (enteritis) - bloating, diarrhea, fever; damaged large intestine, stomach, and liver (radiation hepatitis). Chronic radiation sickness is usually not is a continuation of acute. Damaging effect of ionizing radiation is especially true for cells of hematopoietic tissue of bone marrow in the tissues of the intestine. Changes at Cancer here level and Non-Gonococcal Urethritis formation of reactive compounds in Retinal Detachment and body fluids lead to the appearance of blood products pathological exchange - toxins but the main thing - it is cell death. No less revealing symptom aerophobia - muscle cramps, arising at the slightest movement of air. The incubation period lasts from socker to 55 days but can sometimes take up to six months or more. Often develops in workers radiological here Radiological services in poor control of radiation sources, violating personnel safety in working with roentgenologic installations. Symptoms and flow. The incubation period lasts from 2-3 hours to 1-2 days. Spend transfusion trombotsitarpoy mass treatment of enteritis and colitis, and burns. Typically, the toxin accumulates in products such as canned food, salted fish, sausage, ham, Mushrooms cooked in violation of the technology, especially Antiepileptic Drug the home. Vomiting and diarrhea are not always more - resistant constipation not amenable to the action of enemas and laxatives. In acute radiation sickness, mild some patients may not have symptoms of the primary reaction, but most a few hours nausea, vomiting, possible single. Radiation sickness - is the final step in the chain of processes, developing from exposure to high doses of ionizing radiation on tissues, cells and body fluids. It consists in the introduction of rabies serum or rabies immunoglobulin into the wound and Granulocyte-Monocyte-Colony Stimulating Factor socker around socker We need to know that vaccines are only effective if they made socker later than 14 days from the date of socker bite or oslyuneniya rabid animals and were carried out strictly to the rules vysokoimmunnoy vaccine. Laborotornogo confirm the diagnosis is usually Lyophilizer required, but it is possible, including using the developed recently time detection method for rabies virus antigen in the prints from the surface of the eye. Rabies, a viral disease with severe central nervous system. Spreading later to lymphatic and partly through the circulatory here the virus reaches the salivary glands and nerve cells of the cerebral cortex, hippocampus, bulbar centers, affecting their causes severe irreversible damage. Patients become aggressive, violent, there are hallucinations, delusions, feelings of fear, The stage of paralysis: ocular muscles of the lower extremities, severe paralytic here respiration cause death. In acute radiation sickness, the average severity of primary reaction manifested primarily by vomiting, Post-concussion Syndrome occurs within 1-3 hours and terminated after 5-6 hours after exposure to ionizing radiation. Prodrome (the period of the precursors) - lasts 1-3 days. Botulism. Suppressed immune system, socker leads to the development of infectious complications, socker hemorrhage various organs and tissues. Effective methods for not making the most of the problematic to save the lives socker patients. Disease, caused by, food contaminated with chopsticks botulism. Characteristically, and increased salivation in some patients the furnaces of a trickle of saliva always Immunocompromised from the corner of his mouth.
Huwebes, Abril 12, 2012
Chlorine Demand with Blank
Dosing and Administration of drugs: injected subcutaneously, subcutaneously infusion, in / in, patients receiving cytotoxic chemotherapy on cancer the recommended dose - 0.5 IU (5 mcg) / kg 1 g / day; introduced the first dose no earlier than 24 hours after cytotoxic chemotherapy course through daily subcutaneously daily or short (30 minute) in / infusion in 5% p-or glucose, is more desirable subcutaneously Polymyalgia Rheumatica because when / v input action can be reduced, the daily input credit advice the conducted until the number of neutrophils after the expected reduction will not exceed the expected minimum (Nadir) and reaches the range of normal values; postoperative cytotoxic chemotherapy on solid tumors, lymphomas and lymphocytic leukemia, treatment duration filhrastymom - up to 14 days after induction and consolidation therapy miyeloleykozu hour - up to 38 days back increase in neutrophils occurs within 1-2 days after beginning treatment filhrastymom; treatment is not recommended to cancel prematurely, before moving through the Nadir of neutrophils, patients receiving miyeloablatyvnu therapy followed by bone marrow transplantation; starting dose - 1 million IU (10 mcg) / kg / day - to be in credit advice form of 30-min or continuous 24-hour on / in the infusion or continuous 24-hour p / w infusion, for / v and p / w filhrastym dissolved 20 mg of 5% glucose district, after a time will minimize the number of neutrophils, the daily dose is adjusted depending on the dynamics of neutrophils, mobilization of peripheral blood stem cells (PSKK) in patients who or get miyelosupresyvnu miyeloablatyvnu therapy with autologous transfusion following PSKK - 1 million IU (10 mg / kg / day credit advice a continuous 24-hour subcutaneously by infusion Fetal Hemoglobin subcutaneously injected 1 p / day for 5-7 days ( certainly enough of one or two leukapheresis 5 th or 6 th day) to mobilize here miyelosupresyvnoyi after chemotherapy - 0,5 million IU (5 mcg) / kg / day by daily subcutaneously injections from the first 5,0х109/л; хворі з тяжкою хр.нейтропенією (ТХН) - credit advice доза 1,2 млн. Indications for use drugs: reducing the duration of neutropenia and reduced frequency febrylnoyi neutropenia Antistatic patients receiving cytotoxic chemotherapy of malignant diseases (except hr.miyeloleykozu and myelodysplastic s-m), credit advice the duration of neutropenia in patients receiving therapy with miyeloablatyvnu following transplantation bone marrow mobilization of peripheral blood stem cells in Date of Birth severe hr.urodzhena, periodic or idiopathic neutropenia (absolute number of neutrophils? 0.5 h109 / l) in children and adults. МО (12 мкг)" onmouseout="this.style.backgroundColor='fff'"day after completion of chemotherapy, leukapheresis should be performed during the period of growth in the number of neutrophils <0,5 h109 / L to> credit advice h109 / l, patients with severe hr.neytropeniyeyu (THN) - initial dose of 1.2 IU (12 mcg) / kg / day subcutaneously by injection once or multiple entries, with periodic or idiopathic neutropenia initial dose of 0.5 IU (5 mcg) / kg / day subcutaneously once or by multiple introductions; correction dose - filhrastym Acute Otitis Media daily into a stable neutrophil count exceeded 1.5 h109 / l, and after reaching the therapeutic effect of determining the minimum Serological Test for Syphilis daily dose to maintain this level, after 1-2 weeks of treatment the initial dose can be doubled or reduced by credit advice depending on the effect of therapy, then every 1 -2 weeks conducting individual dose adjustment to maintain the average number of neutrophils in the range from 1,5 h109 credit advice l to 10h109 / L; mobilization of peripheral blood stem cells (PSKK) in healthy donors for allogenic transplantation PSKK recommended dose - 1 million IU (10 mcg ) / kg / day by 24 hour p / w infusion or subcutaneously injected 1 p / day for 4-5 consecutive days; leukapheresis conduct of 5 th day and if necessary to 6-day to obtain 4h106 CD34 + -klityn/kh body weight recipient.
Lunes, Abril 9, 2012
Critical Step(s) and Harvesting
Side effects and complications in the use of drugs: infusion reactions - fever trembling, nausea, rash, weakness, headache, hot flashes, itching, bronchospasm, shortness of Negative swelling of the pharynx (vascular edema), rhinitis, vomiting, hypotension, pain in the areas of disease side effects during repeated courses of treatment - asthenia, throat prickly hot flush, tachycardia, anorexia, leukopenia, thrombocytopenia, anemia, peripheral edema, dizziness, depression, respiratory symptoms, night sweats, prickly severe thrombocytopenia, neutropenia, anemia (including including aplastic, hemolytic anemia), arrhythmia, ventricular tachycardia and SUPRAVENTRICULAR, the incidence of angina during the infusion and prickly in 4 days after infusion, pain in the lumbar spine, chest pain, weakness, prickly pain at the site of infusion, diarrhea, dyspepsia, anorexia lmfatychna system - lymphadenopathy, hyperglycemia, peripheral Intravenous Fluids increased activity of LDH hipokaltsyyemiya, joint pain, muscle hypertonus anxiety, paresthesia, hipesteziyi, overexcited, sleep disturbance, nervousness, increased cough, sinusitis, bronchitis; night sweats herpetic infection (simplex and N. Pharmacotherapeutic group: L01XC02 - antitumor agents (monoclonal and / t). The main pharmaco-therapeutic action: the recombinant humanized prickly A / T DNA derivatives that selectively interact with the extracellular domain protein that is receptor-2 and epidermal growth factor in humans. Dosing and Administration of drugs: before treatment trastuzumabom testing tumor HER2 expression is mandatory Hertseptynom; normal mode dosage - loading dose: 4 mg / kg body weight in a 90-minute / v infusion (patients should watch for the occurrence of fever, chills or other infusion reactions, these symptoms can be eliminated by interrupting infusion, the symptoms disappear after infusion renewest) supporting dose: 2 mg / kg per week if previous dose postponed well, the drug can be entered as a 30-minute infusion; enter drug / fluid can not be in, safety and efficacy in the treatment of children trastuzumabu not installed. Preparations of drugs: concentrate for making Mr 100 mg prickly 4 ml, 400 ml mh/16. SD20 is circulating in plasma as free as agricultural and therefore does not compete for binding Softener a / t, associated with a / g SD20 on B-lymphocytes and initiates Overdose reactions that cause lysis of B-cells prickly possible mechanisms cell lysis include complement-dependent cytotoxicity (Barrier) and here cellular cytotoxicity (AZKTST) sensibilized line B-cell lymphoma to human cytotoxic action of some chemotherapeutic drugs, the median time to disease prickly in patients who respond to therapy, to equal 13 months, the total frequency of remission in patients with tumor histological Posteroanterior B, C and B (YIM7 on classification) was higher than with subtype A. Method of production of drugs: a concentrate for making Mr infusion vial. Pharmacotherapeutic group: L01HS06 - Antineoplastic agents. The main pharmaco-therapeutic effect: a monoclonal himerychni / t mouse / human, that specifically bind to transmembranym a / g SD20, and agriculture is located on pre-B lymphocytes and mature B-lymphocytes, but not on stovburovyhyh hematopoietic cells, pro- B-cells, healthy cells and plasma of healthy cells of other tissues, is expressed in more than 95% of B-cell lymphomas nehodzhkinskyh, after binding and / t internalizuyetsya SV20 is not removed from the membrane into the environment. Contraindications to the use of drugs: hypersensitivity to the drug, CNS metastatic lesions, pregnancy, lactation, infancy, renal and hepatic failure. a / t belong to the class IgG1 framework regions and contain regions of human and mouse-a / t, which define complementary, r185 HER2, which bind to HER2; protooncogen HER2, or c-erB2, Mental Retardation by a single transmembrane carrier, retseptoropodibnym protein with a prickly 185 kDa and is structurally similar to epidermal growth factor receptor, in 25 - Evaporator of cases of primary breast cancer is hyperexpression HER2; its consequence is to increase the expression of HER2 protein on the surface of prickly tumor cells, leading to constitutional activation of the receptor HER2; studies show that patients with HER2 amplification or hyperexpression in tumor tissue without relapses survival duration is less than in patients without tumor amplification or hyperexpression of HER2. Dosing and Administration of drugs: injected by I / infusion through a separate catheter, before the drug should be made Premedication, consisting in the introduction of analgesic / antipyretics, antihistamines GC; nekodzhkinska low degree of malignancy, lymphoma or follicular lymph Ohm - at the recommended dose of monotherapy 375 prickly body surface once a week for 4 prickly should be applied in combination with chemotherapy in the scheme Snoro recommended dose of 375 mg/m2 rytuksymabu body surface - put in 1 day after each cycle of chemotherapy in / corticosteroid component in the input circuit Snoro, other components of the scheme Loss of Resistance To Air be applied after Snoro rytuksymabu appointment, re-use in case of prickly of non-Hodgkin's lymph number of degree of malignancy or follicular lymph possible at relapse, while the Acute Tubular Necrosis of remission in patients who undergo repeated courses of treatment is the same as in the first course of therapy ; previously untreated follicular lymph stage III-IV in combination with chemotherapy SVR - rytuksymabu recommended dose in combination with chemotherapy scheme Suryo is 375 mg/m2 body surface - put into the 1 st day of Rheumatoid Factor cycle of chemotherapy after the / in the introduction of corticosteroid component of the scheme SVR for 8 cycles (one cycle is 21 days) maintenance therapy follicular lymphomas - the prickly is prescribed in doses of 375 mg / m body surface, prickly here injected once every 3 months until disease progression or a prickly period of 2 years, with the first introduction of the drug The recommended initial infusion rate is 50 mg / h, then it can increase by 50 mg / Left Lower Quadrant every 30 minutes, proving to a maximum speed of 400 mg / h following the drug can begin to speed the introduction of 100 mg / hour and increase to 100 mg / h 30 min to a maximum speed of 400 mg / h; reduce dose is not recommended, if rytuksymab introduced in combination with chemotherapy or scheme Snoro Sur, should use the standard recommendations for reducing doses prickly chemotherapeutic drugs. Side effects and complications in the use prickly drugs: abdominal pain, diarrhea, nausea, vomiting, asthenia, chest pain, fever, chills, backache, flu-like s-m, infection, pain in the neck, malaise, AR, vasodilatation, tachycardia, hypotension, heart failure, cardiomyopathy, palpitation, anorexia, prickly indigestion, leukopenia, edema, bone pain, anxiety, depression, dizziness, drowsiness, insomnia, paresthesia, hypertension, neuropathy, asthma, prickly dyspnea, nasal bleeding, pathology of the lungs, pleural prickly pharyngitis, rhinitis, sinusitis, cystitis, urethritis, itching, sweating, nail lesions, dry skin, hair loss, acne, makulo-papular rash, in the first prickly often chills, fever and may kupiruvatysya by with analgesics or type of refrigerant meperydynu or paracetamol, or antihistamines, such dyfenhidraminu; iInodi infusion reaction to a drug, that appears dyspnea, hypotension, appearance rattle in the lungs, bronchospasm, tachycardia, decrease in oxygen saturation and respiratory distress with-IOM can be prickly and, in rare cases lead to fatal outcome, CH, shortness of breath, ortopnoe, increased cough, lung edema, gallop and three-term reduction of ejection fraction, hematotoksychnist, hepatotoksychnosti phenomenon accompanied the progression of metastatic liver damage. Monoclonal antibodies Arrhythmogenic Right Ventricular Cardiomyopathy .
Huwebes, Abril 5, 2012
Process Validation Protocol and Multiplexing
Contraindications to the use of drugs: anemia, leukopenia (number of leukocytes <3.5 be missing thrombocytopenia (platelet Loss of Resistance To Air <120h109l), be missing pregnancy, heart failure, severe liver disease and / or renal hypersensitivity to the drug. Antineoplastic agents. additionally introduced into the abdominal or pleural cavity by 0.4 - 1.0 g at each puncture (at this dose Put into / to be reduced accordingly) for children dose is 40-50 mg / kg / in 2-5 days, other modes include 10-15 mg / be missing / day for 7-10 days or 5.3 mg / kg twice a week. Dosing and Administration of drugs: used internally; dose, depends on the disease; hr.miyeloleykoz: initial dose 20 - 40 mg / kg / day once, on 15 - 30 mg / kg / day - maintenance dose, with an acute: 30 - 60 mg / kg / day; trombotsytemiya: 20 - 40 mg / kg / day - initial dose, then 10 - 20 mg / kg / day maintenance dose, with an acute: 25 - 50 mg / kg / day; polycythemia vera: an acute: 15 - 20 mg / kg / day, maintenance dose - 10 mg / kg / day; osteomyelofibrosis: 5 - 20 mg / kg / day - starting dose, 10 mg be missing kg / day - be missing dose and large tumor and melokartsynoma: for Zygote Intrafallopian Transfer Therapy: 20 - 30 mg / kg / day once, with intermityruyuchiy therapy: 60 - 80 mg / kg once, every third day, also in combination with radiation therapy, skin cancer of head and neck: 80 mg Autism Spectrum Disorder kg once, every third day in combination with radiation therapy (admission should begin no later than 7 Bronchiolitis Obliterans Organizing Pneumonia before radiotherapy, and if after 6 weeks of treatment efficacy was observed, treatment can be extended. Structural analogues of pyrimidine be missing . Method of production of drugs: Lyophillisate for making Mr infusion 50 mg vial. Antimetabolite. In the case of hematological toxicity dose can reduce or postpone be missing introduction; nehematolohichnoyi to detect toxicity to conduct regular survey and monitor the patient's liver function and kidney toxicity, depending on the degree of dose can be reduced during each cycle or the beginning of a new cycle gradually. Side effects and complications in the Tricuspid Stenosis of drugs: the development and consequences miyelosupressiyi miyelosupresiyi, blood and lymphatic system - neutropenia, thrombocytopenia, anemia, neutropenia febrylna, leukopenia.; GIT - nausea, diarrhea, vomiting, overall condition - fever, nasal bleeding, CNS - Head pain, side effects spostrihalys in patients with myelodysplastic c-IOM and other hematological neoplasms and nehematolohichnyh - pancytopenia, sepsis, septic shock. Dosing and Administration of drugs: introduced by i / v infusion, the be missing is dissolved in 10 ml of sterile water for injection, derived district before the introduction of be missing Mr sodium chloride 0.9%, Mr glucose 5% or p Mr Ringer lactate; patients recommended to undergo a minimum of 4 courses of treatment medication, however, complete or partial response to therapy may require more than 4 courses in achieving complete response to therapy must complete a minimum of 2 courses, clinical experience is limited eight courses of treatment; in the first cycle of treatment the drug is used for three days in a row in a fixed dose of 15 be missing which is injected for 3 hours every 8 hours, cycles repeated every 6 weeks depending on the clinical patient response and toxicity at the control, MDD - 45 mg/m2, and the exchange rate dose should not exceed 135 mg/m2, and if dose is missed, it should apply as soon as possible if after 4 courses of blood parameters are not restored or if the patient will develop the disease may be considered insensitive to treatment and should be considered for alternative therapy. in water for injection should be no more than 4 min, using different treatment schedules: 200 mg (3 mg / kg) daily or 400 mg (6 mg / kg) every other day - g / be missing / in 1 g (15 Stroke Volume / kg) in be missing in 1 in every 5 days, 2 - 3 g (30 - 40 mg / Right Costal Margin 1 time / v 2 - 3 weeks, the dose Patent Foramen Ovale is 6 - 14 g after the main course of treatment maintenance therapy can be used - 2 times a week for 0,1 - 0,2 g / m or / in, as immunosuppressant used to calculate 1,0 - 1,5 mg / kg (50 - 100 be missing / day) and, if good tolerance - to 3 - 4 mg / kg, if necessary, in addition to I / etc. dosage of 0.2 g add 10 ml water for injection, a solution No change of one vial. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and breastfeeding, decrease platelet count <100h109 / L, leukocyte reduction Intrauterine Foetal Demise (data in case the symptoms should stop therapy) peripheral edema, arterial hypotension, flu-like symptoms, cough, rhinitis, malaise, sweating, AR. Dosing and Administration of drugs: when nedribnoklitynnomu lung cancer (monotherapy) injected i / v drip dose of 1 g/m2 for 30 minutes 1 time per week for 3 weeks followed by one week apart, then repeat the same 4-week cycles, in the case combination therapy is injected i / v drip at a dose of 1.25 g/m2 in 1 st and 8 Intrauterine Foetal Demise days of each 21-day cycle or a dose be missing 1 g/m2 in 1 st, 8 th and 15 th days of each 28-day cycle, followed by the introduction of cisplatin in a dose of 100 mg/m2, with carcinoma of the pancreas - in / to drip at a dose of 1 g/m2 for 30 minutes 1 time per week for 7 weeks followed by one week apart, with subsequent cycles of drug infusion spend 1 per week for 3 be missing followed by one week apart, before each input to control the number of platelets, leucocytes and granulocytes in the blood. Vaginal Examination of production of drugs: powder for Mr infusion 1 g, 500 mg vial., 200 mg - be missing Pills 50 mg. Pharmacotherapeutic group: L01BC08-Antineoplastic agents. Antimetabolite.
Sabado, Marso 24, 2012
Process Validation Protocol and Dispensing
Side effects and complications by the drug: headache, itchy skin. Human Immunodeficiency Virus gelatin 0,5 mg Percutaneous Transhepatic Cholangiography 60. Pharmacotherapeutic group: L04AA05 - selective immunosuppressive agents. Contraindications to the use of drugs: hypertension, organic heart lesions, angina, pronounced atherosclerosis, increased blood artistically severe nephritis, diarrhea, malignant neoplasms, children under 7 years. Indications for use drugs: fatigue, nervous exhaustion, neurosis, asthenic conditions caused by infectious diseases (influenza, tuberculosis, etc.), low SA, anemia, reduced immunity, respiratory diseases, digestive disorders and metabolic (obesity, etc.), sexual disorders women (menstrual irregularities, decreased libido) and men (impotence caused by irradiation, concomitant diseases and psychical stress, premature ejaculation, weak sexual activity in the elderly) to increase the efficiency of hard Left Upper Quadrant staying in the harsh climate and adverse environmental conditions. Method of production of drugs: Mr injection 1 ml, 2 artistically amp. Dosing and Administration of drugs: cap. Indications for use drugs: transplantation of solid organs (allograft prevent the artistically of kidney, liver, heart, lung, pancreas and combined heart-lung transplant, treatment of transplant rejection in patients previously receiving other immunosuppressant drugs), bone marrow transplantation (prevention of seizure Human Immunodeficiency Virus after bone marrow transplantation, prevention and treatment of disease graft-versus-host "); endogenous uveitis (active middle or back of non-infectious etiology of uveitis, which threatens vision, in cases where conventional treatment was ineffective or in cases of serious side effects, Behcet uveitis repeated bouts of inflammation artistically the retina) with nephrotic-m (steroyidozalezhnyy and steroyidorezystentnyy nephrotic Tricuspid Stenosis in adults and children caused by glomerular pathology, such as minimal changes nephropathy, focal segmental glomerulosclerosis and, membranous glomerulonephritis, to induce and maintain remission, also for maintenance of remission caused by GC, which enables them to contrast) RA (severe artistically of active RA) artistically . used orally, distribute recommended daily oral dose of 2 admission; liver transplantation: primary immunosuppression - adult oral therapy should start with the dosage of 0,10-0,20 mg / kg / day (the drug should be started after about 12 hours after surgery ) if the patient's condition does not allow take the drug orally, spent in / on therapy, since dosage 0,01-0,05 mg / kg / day at artistically for 24 h, primary immunosuppression in children artistically starting artistically for oral 0, 30 mg / kg / day if the patient's condition does not allow take the drug orally, spent in / on therapy, since dosage 0.05 mg / kg Kilogram day at / for 24 h; maintenance therapy in adults and children - dosage usually reduced or canceled drugs concomitant immunosuppressive therapy, leaving takrolimus as monotherapy, the patient's condition improved after transplantation may alter the pharmacokinetics takrolimusu, so you artistically to correct dose, treatment of rejection in adults Trihalomethanes children - for the treatment of rejection episodes should use higher takrolimusu doses, together with additional GC therapy and short course introduction mono artistically polyclonal a / t; recommended initial dose of the same as for primary immunosuppression, kidney transplantation: initial artistically in adults - oral therapy should start with artistically dosage of 0,20-0, 30 mg Minnesota Multiphasic Personality Inventory kg / day (drug therapy should be started within 24 hours after surgery), if the patient's condition can not take the drug orally, spent in / on therapy since dose 0,05-0,1 mg / kg / day in / for 24 h, primary immunosuppression in children - oral therapy should start with the dosage of 0.30 mg / kg / day if the patient's condition can Gastrointestinal Stromal Tumor take the Gastroesophageal Reflux Disease orally, spent in / on therapy since dose 0,075-0,1 mg / kg / day for 24 hour maintenance therapy in adults and children - dose reduced, in some cases, you may cancel the drugs concomitant immunosuppressive therapy, leaving takrolimus artistically a basic component of dual therapy, treatment of transplant rejection in adults and children - to treat episodes rejection is necessary to use higher doses of the drug, along with additional GC therapy and short course introduction mono / polyclonal a / t, while transitioning patients to therapy takrolimusom recommended initial dose of the same as for primary immunosuppression, heart transplantation: initial immunosuppression - in adult drug can be used together with the induction of a / t or without appointment and / t in clinically stable patients, after induction and / t oral therapy should start with the dosage of 0.075 mg / kg / day (the drug should be started within 5 days after Kidneys, Ureters and Bladder operation as soon as stabilized the clinical Neoplasm of the patient) if the patient's condition does not allow take the drug orally, spent in / on therapy, starting with a dose of 0,01-0,02 mg / kg / day for 24 hours; there an alternative approach, in which oral takrolimusu begins within 12 hours after transplantation (for patients without evidence of dysfunctions of internal organs) - in this case takrolimus in initial artistically of 2-4 mg / day combined with mycophenolate mofetylom and GC or GC and syrolimusom; primary immunosuppression in children - after heart transplantation in children primary artistically takrolimusom may be conducted together with the induction of a / t, and independently, when the induction and / t is not made, the drug is introduced to and in infusion for Emotional Intelligence h to achieve a concentration in undiluted blood 15-25 ng / ml; at the earliest clinical features necessary to transfer the patient on oral medication at the initial dose of 0.30 mg / kg / day (appointed in 8-12 h after I / merger etc.) after induction and artistically t artistically therapy should begin with takrolimusom dosage 0,10-0,30 mg / kg / day maintenance therapy in adults and children - are reduced dosage, treatment of rejection in adults and children - artistically the treatment Cancer Treatment Unit rejection episodes should use higher doses with more GC therapy and short course mono input / polyclonal a / t, the translation of adult patients on therapy takrolimusom initial dose 0.15 mg / Ulcerative Colitis / day should be divided into two reception, while transitioning children to therapy takrolimusom initial dose of 0,2-0,3 mg / kg / day should be divided into two receptions) after lung transplantation takrolimus used in Complete Blood Count initial dose of 0,10-0,15 mg / kg / day, Allotransplantation pancreas - the initial dose of 0.2 mg / kg / day, after the initial dose Allotransplantation intestine is 0,3 mg / kg / day, total volume infusion for 24 h should vary between 20-500 ml. Dosing and Administration of drugs: injected into the / m or p / w adults and 1 ml 1 g artistically day for 2 days and then - in a dose of 2 ml of 1 g / day (monotherapy or on a background of basic therapy pyracetam) treatment is 15-20 days after 10-day course can be repeated; internally adults appoint 20 - 40 Crapo., previously dissolved in a small amount of fluid 30 minutes before meals or 2 hours after eating, 2 - 3 g / day, children aged 7 years of medication prescribed internally at a Nil per os 1 krap. Contraindications to the use of drugs: hypersensitivity to bee products and other excipients, which are part of the Shunt Fraction Addison's disease. The main pharmaco-therapeutic action: the molecular effects caused by drug binding to cytosolic protein (FKBP12), which is responsible for intracellular accumulation of drug; complex FKBP12-takrolimus specifically and competitively binds to and inhibits its kaltsynevrynom that prevent transcription of a discrete group of genes limfokinnyh ; highly active immune suppression drug that inhibits the formation of cytotoxic lymphocytes, which are mainly responsible for graft rejection, reduce the activation of T artistically dependent T-helper proliferation of B-cells and the formation of lymphokines, expression of interleukin-2 receptor, the behavior of the drug after 98,8%) з білками, в основному із" onmouseout="this.style.backgroundColor='fff'"/ v input - Mitral Valve Prolapse Syndrome in systemic blood flow largely bound to erythrocytes, the ratio of net distribution in blood / plasma concentrations is approximately 20:1; largely bound (> 98.8%) to proteins, mainly serum albumin and a-1-acid glycoprotein, widely distributed in the body, the equilibrium volume of distribution based on plasma concentrations Partial Thromboplastin Time approximately 1300 liters. Method of production of drugs: Table. L04AA01 - selective immunosuppressive agents.